AMCP Legislative & Regulatory Briefing - September 2024

AMCP Comments on Medicare CY 2025 Physician Fee Schedule  
On July 31, CMS unveiled a proposed rule covering the CY 2025 Physician Fee Schedule, changes to Part B payment and coverage policies, and the Medicare Prescription Drug Inflation Rebate program, among other policies. 

House Judiciary Committee Holds Hearing on The Role of Pharmacy Benefit Managers 
On Sept. 11, the House Judiciary Subcommittee on the Administrative State, Regulatory Reform, and Antitrust held a hearing to examine the role of Pharmacy Benefit Managers in the healthcare industry. 

AMCP Publishes Legislative Update on California Senate Bill 966 
On Aug. 29, the California State Senate passed SB 966, sending one of the most significant state-level PBM reform bills to the desk of Governor Gavin Newsom (D).

AMCP Advocacy and Policy Committee Applications Now Open
The call for AMCP Public Policy Committee and Legislative and Regulatory Action Committee applications is now open, with applications due by Nov. 2, 2024.

2024 Election Update: Vice President Harris, Former President Trump Express Healthcare Positions at Presidential Debate 
On Sept. 10, presidential candidates Kamala Harris and Donald Trump took to the stage to debate pressing policy issues, including positions on the Affordable Care Act (ACA) and prescription drug pricing. 

Download Briefing